BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (BBOT) Operating income 2023–2025
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. (BBOT) annual operating income history from SEC filings — each fiscal year as reported.
-$145.8MFY2025 · since FY2023: -$41,692 → -$145.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$145.8M | -80.3% |
| FY2024 | -$80.9M | -193853.3% |
| FY2023 | -$41,692 | — |
Source: SEC XBRL filings · For reference only · Not investment advice